INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Ipca Laboratories Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524494	ISIN Demat INE571A01038	Book Value 291.98	NSE Symbol IPCALAB	Dividend Yield (%) 0.27	Market Cap (₹ Cr.) 37,222.21	P/E 38.43	EPS 38.18	Face Value 1

Particulars (₹ Cr)	Sep 2025	Jun 2025	Mar 2025	Dec 2024

Gross Sales/Income from operations	1930.32	1746.9	1638.44	1662.68
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	1,930.32	1,746.90	1,638.44	1,662.68
Other Operating Income	0.00	0.00	0.00	0.00
Total Income from operations (net)	1,930.32	1,746.90	1,638.44	1,662.68
Total Expenses	1,532.47	1,403.11	1,345.04	1,314.40
Cost of Sales	510.65	447.89	445.52	459.26
Employee Cost	411.39	409.91	377.12	358.48
Depreciation, amortization and depletion expense	66.86	63.13	65.19	62.81
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	543.57	482.18	457.21	433.85
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	397.85	343.79	293.40	348.28
Other Income	21.92	25.02	21.49	17.41
Profit from ordinary activities before finance costs and exceptional items	419.77	368.81	314.89	365.69
Finance Costs	11.46	12.06	16.20	10.17
Profit from ordinary activities after finance costs but before exceptional items	408.31	356.75	298.69	355.52
Exceptional Items	0.00	0.00	-281.54	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	408.31	356.75	17.15	355.52
Total Tax	103.57	94.71	82.20	87.96
Net profit from Ordinary Activities After Tax	304.74	262.04	-65.05	267.56
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	304.74	262.04	-65.05	267.56
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	304.74	262.04	-65.05	267.56
Other Comprehensive Income	1.93	-1.89	2.57	-1.31
Total Comprehensive Income	306.67	260.15	-62.48	266.25
Equity	25.37	25.37	25.37	25.37
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	12.01	10.33	8.52	10.55
EPS before Exceptional/Extraordinary items-Diluted	12.01	10.33	8.52	10.55
EPS after Exceptional/Extraordinary items-Basic	12.01	10.33	-2.56	10.55
EPS after Exceptional/Extraordinary items-Diluted	12.01	10.33	-2.56	10.55
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00